SK279058B6 - Substituovaný n-[(2-morfolynyl)alkyl]banzamidový d - Google Patents

Substituovaný n-[(2-morfolynyl)alkyl]banzamidový d Download PDF

Info

Publication number
SK279058B6
SK279058B6 SK2897-87A SK289787A SK279058B6 SK 279058 B6 SK279058 B6 SK 279058B6 SK 289787 A SK289787 A SK 289787A SK 279058 B6 SK279058 B6 SK 279058B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutically acceptable
morpholinyl
acid addition
substituted
acceptable acid
Prior art date
Application number
SK2897-87A
Other languages
English (en)
Slovak (sk)
Other versions
SK289787A3 (en
Inventor
Tatsuya Kon
Shiro Kato
Toshiya Morie
Kazunori Ohno
Katsuhiko Hino
Tadahiko Karasawa
Naoyuki Yoshida
Original Assignee
Dainippon Pharmaceutical Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co. filed Critical Dainippon Pharmaceutical Co.
Publication of SK289787A3 publication Critical patent/SK289787A3/sk
Publication of SK279058B6 publication Critical patent/SK279058B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK2897-87A 1986-04-30 1987-04-24 Substituovaný n-[(2-morfolynyl)alkyl]banzamidový d SK279058B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10155286 1986-04-30
JP31509086 1986-12-31

Publications (2)

Publication Number Publication Date
SK289787A3 SK289787A3 (en) 1998-06-03
SK279058B6 true SK279058B6 (sk) 1998-06-03

Family

ID=26442419

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2897-87A SK279058B6 (sk) 1986-04-30 1987-04-24 Substituovaný n-[(2-morfolynyl)alkyl]banzamidový d

Country Status (18)

Country Link
US (1) US4870074A (ko)
EP (1) EP0243959B1 (ko)
KR (1) KR870010030A (ko)
AR (1) AR242953A1 (ko)
AU (1) AU592177B2 (ko)
CA (1) CA1291135C (ko)
CZ (1) CZ284687B6 (ko)
DE (1) DE3781195T2 (ko)
DK (1) DK175281B1 (ko)
ES (1) ES2043617T3 (ko)
FI (1) FI87776C (ko)
GR (1) GR3005934T3 (ko)
HK (1) HK18194A (ko)
HU (1) HU198193B (ko)
NZ (1) NZ220120A (ko)
PH (1) PH24049A (ko)
SK (1) SK279058B6 (ko)
SU (1) SU1597101A3 (ko)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
TW213460B (ko) * 1991-02-15 1993-09-21 Hokuriku Pharmaceutical
US5395832A (en) * 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
EP0774460A1 (en) * 1994-03-30 1997-05-21 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compound and use thereof as medicine
JPH11505815A (ja) * 1995-05-23 1999-05-25 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ (2−モルホリニルメチル)ベンズアミン誘導体
EP1324990B1 (en) 2000-09-29 2014-10-29 Glaxo Group Limited Morpholin-acetamide derivatives for the treatment of inflammatory diseases
ATE286897T1 (de) * 2000-11-28 2005-01-15 Smithkline Beecham Plc Morpholinderivate als antagonisten an orexinrezeptoren
JP4829417B2 (ja) * 2001-03-26 2011-12-07 明夫 乾 インスリン抵抗性改善薬
AU2002356418A1 (en) * 2001-10-08 2003-04-22 Sun Pharmaceutical Industries Limited An antispasmodic agent spaced drug delivery system
GB0208158D0 (en) * 2002-03-28 2002-05-22 Glaxo Group Ltd Novel compounds
GB0207447D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207449D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
HUP0201980A3 (en) * 2002-06-13 2008-06-30 Richter Gedeon Nyrt Process for preparing a benzamide derivative and intermediates thereof
JP4740740B2 (ja) * 2003-12-09 2011-08-03 大日本住友製薬株式会社 薬物含有粒子および該粒子を含む固形製剤
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
DK2194053T3 (da) 2004-01-07 2013-07-01 Armetheon Inc Methoxypiperidinderivater til brug i behandling af gastrointestinale forstyrrelser og forstyrrelser i centralnervesystemet.
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
PT1801108E (pt) * 2004-09-08 2012-12-03 Mitsubishi Tanabe Pharma Corp Composto de morfolina para o tratamento de inflamações
AR054623A1 (es) * 2005-06-23 2007-07-04 Astrazeneca Ab PROCESO PARA PREPARAR DERIVADOS DE BENCIMIDAZOL Y COMPUESTOS INTERMEDIARIOS DE SíNTESIS DE LOS MISMOS.
AU2006284601B2 (en) * 2005-08-31 2012-12-20 Renexxion, Llc Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
WO2007075749A2 (en) * 2005-12-20 2007-07-05 Merck & Co., Inc. Niacin receptor agonists, compositions containing such compounds and methods of treatment
KR100750593B1 (ko) * 2006-03-16 2007-08-20 동우신테크 주식회사 치환된 벤즈아미드 유도체의 제조방법
US20080085915A1 (en) * 2006-06-23 2008-04-10 Cyrus Becker Compounds and methods for the treatment of gastrointestinal and central nervous system disorders
JP2010524972A (ja) * 2007-04-19 2010-07-22 コンサート ファーマシューティカルズ インコーポレイテッド 重水素化したモルホリニル化合物
CN101402633A (zh) * 2007-09-11 2009-04-08 上海恒瑞医药有限公司 苯甲酰胺类衍生物、其制备方法及其在医药上的用途
JP4989733B2 (ja) 2008-02-13 2012-08-01 大日本住友製薬株式会社 口腔内崩壊錠
TWI423967B (zh) * 2008-02-21 2014-01-21 Dainippon Sumitomo Pharma Co 醯胺衍生物及含有其之醫藥組合物
CN101565381B (zh) * 2009-06-01 2013-07-24 重庆英斯凯化工有限公司 2-烷氧基-4-氨基-5-氯苯甲酸的制备方法
WO2011019043A1 (ja) 2009-08-11 2011-02-17 大日本住友製薬株式会社 2種以上の粒子を含有する口腔内速崩壊錠
WO2011107903A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Highly pure mosapride citrate dihydrate and processes for its preparation
MX337477B (es) 2011-02-25 2016-03-07 Yuhan Corp Derivados de diaminopiridina y procesos para su preparacion.
KR101657616B1 (ko) 2013-05-24 2016-09-19 주식회사유한양행 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
CN111349052B (zh) * 2020-04-07 2021-02-12 福建海西新药创制有限公司 一种枸橼酸莫沙必利的合成方法
CN114560822B (zh) * 2020-11-27 2024-05-28 鲁南制药集团股份有限公司 一种莫沙必利的二羧酸晶体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH451142A (de) * 1965-01-19 1968-05-15 Sandoz Ag Verfahren zur Herstellung neuer basisch substituierter Benzoesäureamide
US4029786A (en) * 1972-08-11 1977-06-14 Imperial Chemical Industries Limited Morpholine derivatives for treating depression
US4323503A (en) * 1976-08-04 1982-04-06 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene di (oxy) benzamides and derivatives
US4210754A (en) * 1977-02-01 1980-07-01 Hoffmann-La Roche Inc. Morpholino containing benzamides
US4692445A (en) * 1983-04-29 1987-09-08 Rorer Pharmaceutical Corporation Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
JPH0390274A (ja) * 1989-08-28 1991-04-16 Furukawa Alum Co Ltd Al又はAl合金の気相ろう付法

Also Published As

Publication number Publication date
SU1597101A3 (ru) 1990-09-30
GR3005934T3 (ko) 1993-06-07
HU198193B (en) 1989-08-28
DK218787D0 (da) 1987-04-29
DE3781195T2 (de) 1993-02-18
DE3781195D1 (de) 1992-09-24
HUT45514A (en) 1988-07-28
SK289787A3 (en) 1998-06-03
FI87776B (fi) 1992-11-13
AU592177B2 (en) 1990-01-04
NZ220120A (en) 1989-06-28
FI871828A0 (fi) 1987-04-27
CZ289787A3 (cs) 1998-11-11
FI87776C (fi) 1993-02-25
US4870074A (en) 1989-09-26
KR870010030A (ko) 1987-11-30
EP0243959A1 (en) 1987-11-04
DK175281B1 (da) 2004-08-09
AR242953A1 (es) 1993-06-30
ES2043617T3 (es) 1994-01-01
FI871828A (fi) 1987-10-31
DK218787A (da) 1987-10-31
CA1291135C (en) 1991-10-22
AU7227587A (en) 1987-11-05
HK18194A (en) 1994-03-11
EP0243959B1 (en) 1992-08-19
CZ284687B6 (cs) 1999-02-17
PH24049A (en) 1990-03-05

Similar Documents

Publication Publication Date Title
SK279058B6 (sk) Substituovaný n-[(2-morfolynyl)alkyl]banzamidový d
EP1554243B1 (en) Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
US5281590A (en) 2-H and 3-alkoxy or hydroxy-8-substituted-dibenz[b,f]-[1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides for the treatment of osteoporosis
US5225409A (en) Benzoxazinone compounds
EP2445340A1 (en) Substituted hydroxamic acids and uses thereof
WO2007129111A1 (en) Diazepine derivatives as 5-ht2a antagonists
US9951044B2 (en) Quinazoline derivatives and their use as DNA methyltransferase inhibitors
KR20090114439A (ko) 아실구아니딘 유도체
US5116995A (en) Carbazole compounds
EA009043B1 (ru) Новые соединения пиридопиримидинона, способ их получения и фармацевтические композиции, которые их содержат
US5173486A (en) Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents
EP0191867B1 (en) Tryciclic or tetracyclic compounds, process for their preparation, and medicinal composition containing them
KR20010022658A (ko) 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-d]피리미딘 유도체, 그의 제법 및 5ht길항제로서의 용도
BG63336B1 (bg) Нови производни на хидроксамови киселини, фармацевтични състави на тяхна основа и метод за получаването им
WO1999038864A1 (en) Oxazole derivatives as serotonin-1a receptor agonists
FI86725B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 5,11-dihydro-6h-pyrido/2,3-b//1,4/-bensodiazepin-6 -oner och 4,9-dihydro-10h-tieno/3,4-b//1,5/bensodiazepin-10-oner.
SK285679B6 (sk) Derivát benzamidu, liečivo s jeho obsahom a ich použitie
US6528504B2 (en) Oxazepine derivatives and medicine containing the same
AU607354B2 (en) Antipsychotic 4-(4-(3-benzisothiazolyl)-1-piperazinyl) butyl bridged bicyclic imides
DK149889B (da) Analogifremgangsmaade til fremstilling af dibenzo(d,g)(1,3,6)dioxazocinderivater eller syreadditionssalte deraf
JPH0291063A (ja) 新規な6,11‐ジヒドロ‐ジベンゾ〔c,f〕〔1,2,5〕チアジアゼピン‐5,5‐ジオキシド誘導体,その塩及びその製造法
AU781768B2 (en) New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them
JPH0616638A (ja) ピリジン化合物およびその医薬用途
JPS6183171A (ja) ジベンゾ〔b,f〕〔1,5〕オキサゾシン誘導体及びその製造法並びにそれを有効成分とする医薬
IE44293B1 (en) Novel n-(4(2-oxo-1-benzimidazolyl)piperidion)alkylbenzamide derivatives,processes for their preparation,and pharmaceutical compositions incorporating them.